Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Real-World Experience of Asciminib: Factors Associated with Response

Blood (2022) 140 (Supplement 1): 6796–6797.

https://doi.org/10.1182/blood-2022-165501

Published: 2022

Journal Articles

CPX-351 for Acute Myeloid Leukaemia: Real World Results Are Comparable to Trial Outcomes and Exceeds Them in Non-Adverse Risk Patients- a Multicentre Experience from West Midlands Hospitals on Behalf of West Midlands Research Consortium ( WMRC) UK

Vidhya Murthy, Richard Whitmill, Clare Lodwick, Peter Dyer, Maria Ahmed, Rehmatullah Khan, Shankara Paneesha, Nicholas Pemberton, Manoj Raghavan

Blood (2021) 138 (Supplement 1): 4416.

https://doi.org/10.1182/blood-2021-150199

Published: 2021

Journal Articles

A Phase 1b Study of Eltrombopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders

Alex Sternberg, MRCP,FRCPath, Rebecca H. Boucher, BSc, MSc, PhD, Helen C Coulthard, BSc, Manoj Raghavan, MBBS, PhD MRCP, FRCPath, Dominic J. Culligan, MD, Aimee Jackson, BSc, MSc, Catherine Cargo, MB, PhD, Mike Dennis, MD, Marlen Metzner, MSc, Rachel Moore, BA, David Bowen, MD, Paresh Vyas, MRCP, FRCP, FRCPath

Blood (2020) 136 (Supplement 1): 10.

https://doi.org/10.1182/blood-2020-134227

Published: 2020

Journal Articles

The Target UK Study: Real-World Evidence of Molecular Response to Tyrosine Kinase Inhibitors Supports European Leukemianet 2013 Recommendations for the Management of Chronic Myeloid Leukaemia

Dragana Milojkovic, MBBS, PhD, Richard E. Clark, Jennifer L Byrne, Brian J.P Huntly, Manoj Raghavan, Farooq A Wandroo, Sahra Ali, Belinda Austen, Jacqueline Ryan, Karsten Friedrich, Nicholas C.P. Cross, PhD, Adam J Mead, MD PhD

Blood (2017) 130 (Supplement 1): 2892.

https://doi.org/10.1182/blood.V130.Suppl_1.2892.2892

Published: 2017

Journal Articles

Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Charles Craddock, MD PhD, Aimee E Houlton, BSc, MSc, Paul Ferguson, MBChB MRCP PhD, Manoj Raghavan, Sonia Fox, Louise Dudley, BSc, MRes, Lynn Swun Quek, FRCPath, DPhil, MBBS, Jamie D. Cavenagh, Michael Dennis, FRCPath, Mary Frances McMullin, MD, Srinivas P Pillai, Richard Kelly, BSc, MD, Shamyla Siddique, Keith Wheatley, DPhil, Paresh Vyas, BM, DPhil, FRCP, FRCPath

Blood (2016) 128 (22): 1065.

https://doi.org/10.1182/blood.V128.22.1065.1065

Published: 2016

Journal Articles

Genetic Analysis Using a High Density SNP Array in Myelodysplastic Syndrome: Clinical Utility and Comparative Analysis Study Compared to Metaphase Chromosome Analysis

Sally Jeffries, Nicola Trim, Emma Huxley, Laura Ford, Manoj Raghavan, Jane Soden, Michael John Griffiths, BSc

Blood (2015) 126 (23): 5259.

https://doi.org/10.1182/blood.V126.23.5259.5259

Published: 2015

Journal Articles

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

David Burns, Shabeeha Rana, Andrew Howman, Sandeep Nagra, Janice Ward, Husam Osman, Yusri Taha, Jenny Byrne, Emma Das-Gupta, Manoj Raghavan, Ram Malladi, Mark Cook, Prem Mahendra, Nigel H. Russell, MD, Charles Craddock, Christopher Fox, Sridhar Chaganti

Blood (2012) 120 (21): 460.

https://doi.org/10.1182/blood.V120.21.460.460

Published: 2012

Journal Articles

Survival Outcomes in Patients with FLT3 -Itd Positive Acute Myeloid Leukaemia Relative to Biological Stratification: Smaller FLT3 -Itd Clone Size Predict Better Overall Survival

Justin Ching Ting Loke, Susanna Akiki, Joanne Ewing, Syed W Bokhari, Deepak Chandra, Julie Arrazi, Peter Hazlewood, Katherine Arthur, Julie Walsh, Yvonne Membwange, Farooq Ahmad Wandroo, Angela Watts, Charles Craddock, Mike Griffiths, Manoj Raghavan

Blood (2012) 120 (21): 1460.

https://doi.org/10.1182/blood.V120.21.1460.1460

Published: 2012

Journal Articles

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

Blood (2012) 119 (14): 3361–3369.

https://doi.org/10.1182/blood-2011-09-377044

Published: 2012

Includes: Supplemental data

Journal Articles

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

Charles F. Craddock, MD PhD, Nicolas Goardon, PhD, Lynn Quek, MD, Sylvie Freeman, MD, PhD, Shamyla Siddique, Manoj Raghavan, Anna Schuh, PhD, David Grimwade, PhD, Robert K Hills, MA, MSc, DPhil, Cassandra Brookes, PhD, Michael Griffiths, PhD, James D. Cavenagh, MD, Ravindra Majeti, MD, PhD, Irving L. Weissman, MD, Alan K Burnett, MD, Paresh Vyas

Blood (2011) 118 (21): 638.

https://doi.org/10.1182/blood.V118.21.638.638

Published: 2011

Journal Articles

Pre-Emptive Rituximab for Epstein-Barr Virus Reactivation Post Stem Cell Transplant: High CRP and PTLD At Initiation of Treatment Confer Inferior Outcome

David Burns, Sandeep Nagra, Husam Osman, Ram Malladi, Manoj Raghavan, Fiona Clark, Mark Cook, Prem Mahendra, Charles Craddock, Sridhar Chaganti

Blood (2011) 118 (21): 3007.

https://doi.org/10.1182/blood.V118.21.3007.3007

Published: 2011

Journal Articles

Clonal Evolution of Multiple TET2 mutations In the Transformation of Chronic Myelomonocytic Leukemia to Acute Myeloid Leukemia and Its Subsequent Relapse

Robert D. Petty, BSc, Farideh Miraki-Moud, Tracy Chaplin, Grossmann Vera, Daverio Andrea, Finlay Macdougall, Maria Ronayne, Bryan D Young, BSc, PhD, Manoj Raghavan, MBBS, PhD

Blood (2010) 116 (21): 2699.

https://doi.org/10.1182/blood.V116.21.2699.2699

Published: 2010

Journal Articles

Genome-Wide Micro-Deletions and Amplifications Acquired at Relapse in Acute Myeloid Leukemia.

Manoj Raghavan, MBBS, PhD, MRCP, FRCPath, Manu Gupta, PhD, Tracy Chaplin, MSc, Sabah Khalid, PhD, T. Andrew Lister, Bryan D Young, PhD

Blood (2009) 114 (22): 166.

https://doi.org/10.1182/blood.V114.22.166.166

Published: 2009

Journal Articles

Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia

Manoj Raghavan, Lan-Lan Smith, Debra M. Lillington, Tracy Chaplin, Ioannis Kakkas, Gael Molloy, Claude Chelala, Jean-Baptiste Cazier, James D. Cavenagh, Jude Fitzgibbon, T. Andrew Lister, Bryan D. Young

Blood (2008) 112 (3): 814–821.

https://doi.org/10.1182/blood-2008-01-132431

Published: 2008

Journal Articles

A Genome-Wide Map of Acquired Uniparental Disomy in Acute Myeloid Leukemia.

Manu Gupta, Manoj Raghavan, Rosemary E. Gale, Claude Chelala, Christopher Allen, Gael Molloy, Tracy Chaplin, David C. Linch, Jean-Baptiste Cazier, Bryan Young

Blood (2007) 110 (11): 996.

https://doi.org/10.1182/blood.V110.11.996.996

Published: 2007

Journal Articles

aUPD in the Clonal Evolution of Follicular Lymphoma.

Derville O’Shea, Sameena Iqbal, Emanuela Carlotti, Andrew Davies, Tracy Chaplin, Janet Matthews, Manoj Raghavan, Andrew Norton, T. Andrew Lister, Bryan D. Young, Jude Fitzgibbon

Blood (2006) 108 (11): 2065.

https://doi.org/10.1182/blood.V108.11.2065.2065

Published: 2006

Journal Articles

Identification of New Genomic Lesions in Childhood ALL without Known Genetic Aberrations: A Microarray Study of Gene Expression and Genotype Data.

Silvia Bungaro, PhD, Marta Campo Dell’Orto, MSc, Dario Basso, MSc, Tatiana A. Gorletta, MSc, Manoj Raghavan, MD, Anna Leszl, MSc, Bryan D. Young, PhD, Giuseppe Basso, MD, Gertruy te Kronnie, PhD, Silvio Bicciato, PhD, Andrea Biondi, MD, Giovanni Cazzaniga, PhD

Blood (2006) 108 (11): 2066.

https://doi.org/10.1182/blood.V108.11.2066.2066

Published: 2006

Journal Articles

An Increased Frequency of Abnormalities Including Uniparental Disomy Is Detected by SNP Array Compared with Conventional Karyotype Analysis in Acute Myeloid Leukemia.

Manoj Raghavan, MRCP, MRCPath, Rosemary E. Gale, Phd, Spyros Skoulakis, Phd, Tracy Chaplin, BSc, Gael Y. Molloy, BSc, David C. Linch, Phd, FRCP, FRCPath, Alan K. Burnett, Phd, FRCP, FRCPath, Bryan D. Young, Phd, FAcadSci

Blood (2005) 106 (11): 97.

https://doi.org/10.1182/blood.V106.11.97.97

Published: 2005

Journal Articles

Dissection of Submicroscopical Aberrations and Clonal Evolution from Birth To Diagnosis and Relapse in a Childhood AML FLT3-ITD Positive Patient by RQ-PCR and SNP Array Analyses.

Giovanni Cazzaniga, PhD, Silvia Bungaro, MSc, Manoj Raghavan, MD, Chiara Beretta, MD, Maria G. Dell’Oro, MD, Lucilla Lecchi, MD, Vincenzo Rossi, MSc, Paolo Rebulla, MD, Bryan D. Young, MD, Andrea Biondi, MD

Blood (2005) 106 (11): 4337.

https://doi.org/10.1182/blood.V106.11.4337.4337

Published: 2005

Journal Articles

Molecular Characterization of AML1 ( RUNX1 ) Amplification: A Poor Risk Chromosomal Marker in Acute Lymphoblastic Leukaemia (ALL).

Jon C. Strefford, Frederic van Delft, Manoj Raghavan, Hazel M. Robinson, Anthony V. Moorman, Bryan D. Young, Vaskar Saha, Christine J. Harrison

Blood (2004) 104 (11): 140.

https://doi.org/10.1182/blood.V104.11.140.140

Published: 2004

NARROW

Real-World Experience of Asciminib: Factors Associated with Response

CPX-351 for Acute Myeloid Leukaemia: Real World Results Are Comparable to Trial Outcomes and Exceeds Them in Non-Adverse Risk Patients- a Multicentre Experience from West Midlands Hospitals on Behalf of West Midlands Research Consortium ( WMRC) UK

A Phase 1b Study of Eltrombopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders

The Target UK Study: Real-World Evidence of Molecular Response to Tyrosine Kinase Inhibitors Supports European Leukemianet 2013 Recommendations for the Management of Chronic Myeloid Leukaemia

Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Genetic Analysis Using a High Density SNP Array in Myelodysplastic Syndrome: Clinical Utility and Comparative Analysis Study Compared to Metaphase Chromosome Analysis

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

Survival Outcomes in Patients with FLT3 -Itd Positive Acute Myeloid Leukaemia Relative to Biological Stratification: Smaller FLT3 -Itd Clone Size Predict Better Overall Survival

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

Pre-Emptive Rituximab for Epstein-Barr Virus Reactivation Post Stem Cell Transplant: High CRP and PTLD At Initiation of Treatment Confer Inferior Outcome

Clonal Evolution of Multiple TET2 mutations In the Transformation of Chronic Myelomonocytic Leukemia to Acute Myeloid Leukemia and Its Subsequent Relapse

Genome-Wide Micro-Deletions and Amplifications Acquired at Relapse in Acute Myeloid Leukemia.

Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia

A Genome-Wide Map of Acquired Uniparental Disomy in Acute Myeloid Leukemia.

aUPD in the Clonal Evolution of Follicular Lymphoma.

Identification of New Genomic Lesions in Childhood ALL without Known Genetic Aberrations: A Microarray Study of Gene Expression and Genotype Data.

An Increased Frequency of Abnormalities Including Uniparental Disomy Is Detected by SNP Array Compared with Conventional Karyotype Analysis in Acute Myeloid Leukemia.

Dissection of Submicroscopical Aberrations and Clonal Evolution from Birth To Diagnosis and Relapse in a Childhood AML FLT3-ITD Positive Patient by RQ-PCR and SNP Array Analyses.

Molecular Characterization of AML1 ( RUNX1 ) Amplification: A Poor Risk Chromosomal Marker in Acute Lymphoblastic Leukaemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only